Trio of Law Firms Lead GE’s Bet on Surgical Technology Company BK Medical

(Reuters) – Three law firms – Gibson, Dunn & Crutcher, Latham & Watkins and Schiff Hardin – lead General Electric Co’s plan to buy ultrasound system maker BK Medical for $ 1.45 billion in cash with Altaris Capital Partners.

The acquisition of Boston and Copenhagen-based BK Medical, announced Thursday, is GE’s largest since Larry Culp became CEO in 2018.

GE brought in a team from Gibson Dunn led by M&A partner Saee Muzumdar, who counts the company as a corporate client, according to his company profile.

The Gibson Dunn team includes executive compensation and benefits partner Michael Collins; antitrust and competition partners Stephen Weissman, Kristen Limarzi and Attila Borsos; technology partner Daniel Angel; and tax partner Kathryn Kelly.

Latham and Schiff Hardin are acting as co-counsel to BK Medical in connection with the transaction.

The Schiff Hardin team is led by corporate partner Steve Isaacs and includes partners Olga Bogush and Sara Rosenberg.

Issacs advised current BK Medical owner Altaris Capital, a healthcare specialist, on several transactions, including the investment firm’s acquisition of Analogic Corp for $ 1.1 billion in 2018, according to a cabinet press release. Analogic was previously the parent company of BK Medical.

The company has also backed Altaris Capital in its purchases of generic prescription drug company Padagis LLC from Perrigo Co plc for $ 1.55 billion this year, according to a press release from the company.

The sale of BK Medical by Altaris Capital is expected to be finalized in 2022.

GE’s financial advisor is Evercore, and BK Medical is JP Morgan Securities LLC and Morgan Stanley & Co.

Read more:

GE Announces Biggest Acquisition of CEO Culp